IL10 and bronchopulmonary dysplasia: In conclusion, the present study indicated that PMNs of the newly born, the first innate immune cell type invading the fetal membranes, placenta, and umbilical cord [29], as well as the airway of the newborn with evolving BPD [6], [7], [9], do not have the ability to control inflammation by an IL-10 mechanism after LPS stimulation.